Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
PHD finger protein 19 (PHF19) is a polycomb protein that promoted cardiac hypertrophy via epigenetic targeting SIRT2. To determine the role of PHF19 in myocardial hypertrophy, we established a large fragment knockout model of PHF19 gene in human embryonic stem cells (hESCs-H7) using the CRISPR/Cas9 system based on a vector. This PHF19-KO cell line has a normal karyotype, classical human pluripotent stem cell morphology, strong pluripotency, and significantly reduced PHF19 gene expression, which will become a useful tool for further in-depth research on the pathogenesis of PHF19 gene deficiency induced myocardial hypertrophy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.scr.2025.103824 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Generation of a PHF19 knockout human embryonic stem cell line by CRISPR/Cas9 system.
Stem Cell Res
September 2025
Basic Medical Research Center, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325035 Zhejiang, China. Electronic address:
PHD finger protein 19 (PHF19) is a polycomb protein that promoted cardiac hypertrophy via epigenetic targeting SIRT2. To determine the role of PHF19 in myocardial hypertrophy, we established a large fragment knockout model of PHF19 gene in human embryonic stem cells (hESCs-H7) using the CRISPR/Cas9 system based on a vector. This PHF19-KO cell line has a normal karyotype, classical human pluripotent stem cell morphology, strong pluripotency, and significantly reduced PHF19 gene expression, which will become a useful tool for further in-depth research on the pathogenesis of PHF19 gene deficiency induced myocardial hypertrophy.
View Article and Find Full Text PDFComparisons of miRNA profiles of exosomes derived from human iPSCs, ADSCs, and BMSCs and effects on chondrocyte function.
Bone Joint Res
August 2025
Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
Aims: This study aimed to identify and compare the microRNA (miRNA) profiles of exosomes derived from human induced pluripotent stem cells (iPSCs), bone marrow mesenchymal stem cells (BMSCs), and adipose tissue-derived stem cells (ADSCs) (hiPSC-Exos, hBMSC-Exos, and hADSC-Exos), and their functional effects on human articular chondrocytes (hACs).
Methods: hiPSC-Exos, hBMSC-Exos, and hADSC-Exos were collected from the appropriate cells cultured in 10% bovine exosome-depleted fetal bovine serum (de-Exo-FBS) for 48 hours. Next-generation sequencing (NGS) and bioinformatics were used to analyze the small RNA profiles of these exosomes.
Distinct specificity and functions of PRC2 subcomplexes in human stem cells and cardiac differentiation.
Mol Cell
August 2025
Cardiovascular Research Institute, Weill Cornell Medicine, New York, NY 10021, USA; Department of Biochemistry, Weill Cornell Medicine, New York, NY 10021, USA. Electronic address:
The dynamic regulation of epigenetic states relies on complex macromolecular interactions. PRC2, the methyltransferase complex depositing H3K27me3, interacts with distinct accessory proteins to form the mutually exclusive subcomplexes PHF1-PRC2.1, MTF2-PRC2.
View Article and Find Full Text PDFTranscript PHF19-207 May Be a Long Non-Coding RNA with Tumor-Promoting Role in Colon Cancer.
Biomolecules
July 2025
Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11000 Belgrade, Serbia.
Recent pan-cancer transcriptome analysis has revealed differential activity of two alternative gene promoters in malignant versus non-malignant gut mucosa. One of these promoters upregulated in colon cancer leads to the expression of the PHF19-207 transcript, suggesting its potential role in tumor promotion. The objective of this study was to investigate the function of PHF19-207 using in silico tools and publicly available data, as well as to assess its expression in colon cancer.
View Article and Find Full Text PDFHigh PHD finger protein 19 expression predicts inferior prognosis in diffuse large B-cell lymphoma.
Pathology
June 2025
Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address:
PHD finger protein 19 (PHF19) is an epigenetic regulator known to be associated with the prognosis of patients in various tumours, while its impact on the prognosis of diffuse large B-cell lymphoma (DLBCL) remains unexplored. This study aimed to investigate the expression and prognostic significance of PHF19 in DLBCL. PHF19 expression was assessed in 192 DLBCL cases using immunohistochemistry.
View Article and Find Full Text PDF